Click to view 3D structure | Cytochrome P450 2C19 | P33261 | Humans | Known | Not Available |
Click to view 3D structure | Scytalone dehydratase | P56221 | Magnaporthe oryzae (strain 70-15 / FGSC 8958) (Rice blast fungus)(Pyricularia oryzae) | Predicted (SEA) | - Prediction Confidence Score
- 0.266
- Applicability Domain
- 0.266 Low confidence
- Statistical Significance
- 8.00e-04
- Supporting Reference Compounds
- 1
- E-value
- 6.22794
|
Click to view 3D structure | Sodium-dependent serotonin transporter | P31645 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.245
- Applicability Domain
- 0.263 Low confidence
- Statistical Significance
- 0.2277
- Supporting Reference Compounds
- 593
- E-value
- 1772.47
|
Click to view 3D structure | Cytochrome P450 2D6 | P10635 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.24
- Applicability Domain
- 0.263 Low confidence
- Statistical Significance
- 0.5811
- Supporting Reference Compounds
- 1130
- E-value
- 4523.66
|
Click to view 3D structure | 15-cis-phytoene desaturase | P26294 | Synechococcus elongatus (strain PCC 7942) (Anacystis nidulans R2) | Predicted (SEA) | - Prediction Confidence Score
- 0.238
- Applicability Domain
- 0.238 Low confidence
- Statistical Significance
- 0.0221
- Supporting Reference Compounds
- 1
- E-value
- 171.969
|
Click to view 3D structure | Prostaglandin G/H synthase 2 | P35354 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.231
- Applicability Domain
- 0.246 Low confidence
- Statistical Significance
- 0.1748
- Supporting Reference Compounds
- 201
- E-value
- 1360.65
|
Click to view 3D structure | Nitric oxide synthase, inducible | P35228 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.229
- Applicability Domain
- 0.263 Low confidence
- Statistical Significance
- 0.0096
- Supporting Reference Compounds
- 47
- E-value
- 74.5017
|
Click to view 3D structure | Beta-ketoacyl-[acyl-carrier-protein] synthase III | P68795 | Staphylococcus aureus subsp. aureus Mu50 | Predicted (SEA) | - Prediction Confidence Score
- 0.228
- Applicability Domain
- 0.234 Low confidence
- Statistical Significance
- 0.0181
- Supporting Reference Compounds
- 2
- E-value
- 140.596
|
Click to view 3D structure | Beta-ketoacyl-[acyl-carrier-protein] synthase III | Q820T1 | Enterococcus faecalis (strain ATCC 700802 / V583) | Predicted (SEA) | - Prediction Confidence Score
- 0.227
- Applicability Domain
- 0.234 Low confidence
- Statistical Significance
- 0.018
- Supporting Reference Compounds
- 4
- E-value
- 140.44
|
Click to view 3D structure | Beta-ketoacyl-[acyl-carrier-protein] synthase III | P0DB00 | Streptococcus pyogenes serotype M3 (strain ATCC BAA-595 / MGAS315) | Predicted (SEA) | - Prediction Confidence Score
- 0.227
- Applicability Domain
- 0.234 Low confidence
- Statistical Significance
- 0.0181
- Supporting Reference Compounds
- 3
- E-value
- 140.985
|
Click to view 3D structure | Cathepsin K | P43235 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.225
- Applicability Domain
- 0.241 Low confidence
- Statistical Significance
- 0.1331
- Supporting Reference Compounds
- 129
- E-value
- 1035.86
|
Click to view 3D structure | Prostaglandin G/H synthase 1 | P05979 | Ovis aries | Predicted (SEA) | - Prediction Confidence Score
- 0.225
- Applicability Domain
- 0.246 Low confidence
- Statistical Significance
- 0.1156
- Supporting Reference Compounds
- 106
- E-value
- 899.703
|
Click to view 3D structure | Prostaglandin G/H synthase 1 | P23219 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.225
- Applicability Domain
- 0.246 Low confidence
- Statistical Significance
- 0.1435
- Supporting Reference Compounds
- 136
- E-value
- 1117.37
|
Click to view 3D structure | Aldo-keto reductase family 1 member C3 | P42330 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.224
- Applicability Domain
- 0.253 Low confidence
- Statistical Significance
- 0.0982
- Supporting Reference Compounds
- 57
- E-value
- 764.324
|
Click to view 3D structure | Aldo-keto reductase family 1 member C2 | P52895 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.224
- Applicability Domain
- 0.253 Low confidence
- Statistical Significance
- 0.0791
- Supporting Reference Compounds
- 40
- E-value
- 615.943
|
Click to view 3D structure | Voltage-gated inwardly rectifying potassium channel KCNH2 | Q12809 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.223
- Applicability Domain
- 0.263 Low confidence
- Statistical Significance
- 0.8247
- Supporting Reference Compounds
- 1498
- E-value
- 6420.54
|
Click to view 3D structure | Procathepsin L | P07711 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.223
- Applicability Domain
- 0.241 Low confidence
- Statistical Significance
- 0.175
- Supporting Reference Compounds
- 167
- E-value
- 1362.75
|
Click to view 3D structure | Cathepsin B | P07858 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.223
- Applicability Domain
- 0.241 Low confidence
- Statistical Significance
- 0.1811
- Supporting Reference Compounds
- 173
- E-value
- 1409.77
|
Click to view 3D structure | Beta-ketoacyl-[acyl-carrier-protein] synthase III | P43711 | Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) | Predicted (SEA) | - Prediction Confidence Score
- 0.222
- Applicability Domain
- 0.222 Low confidence
- Statistical Significance
- 0.0197
- Supporting Reference Compounds
- 1
- E-value
- 153.285
|
Click to view 3D structure | Cytochrome P450 3A4 | P08684 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.221
- Applicability Domain
- 0.233 Low confidence
- Statistical Significance
- 0.8412
- Supporting Reference Compounds
- 1538
- E-value
- 6548.6
|
Click to view 3D structure | Cathepsin S | P25774 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.221
- Applicability Domain
- 0.241 Low confidence
- Statistical Significance
- 0.1756
- Supporting Reference Compounds
- 141
- E-value
- 1367.42
|
Click to view 3D structure | Cytochrome P450 2C9 | P11712 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.22
- Applicability Domain
- 0.233 Low confidence
- Statistical Significance
- 0.8246
- Supporting Reference Compounds
- 1245
- E-value
- 6419.68
|
Click to view 3D structure | Sodium-dependent noradrenaline transporter | P23975 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.219
- Applicability Domain
- 0.227 Low confidence
- Statistical Significance
- 0.4465
- Supporting Reference Compounds
- 451
- E-value
- 3476.36
|
Click to view 3D structure | Dipeptidyl peptidase 1 | P53634 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.217
- Applicability Domain
- 0.236 Low confidence
- Statistical Significance
- 0.0859
- Supporting Reference Compounds
- 44
- E-value
- 668.803
|
Click to view 3D structure | Sodium-dependent dopamine transporter | Q01959 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.216
- Applicability Domain
- 0.227 Low confidence
- Statistical Significance
- 0.5458
- Supporting Reference Compounds
- 506
- E-value
- 4249.4
|
Click to view 3D structure | Cytochrome P450 2C19 | P33261 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.215
- Applicability Domain
- 0.233 Low confidence
- Statistical Significance
- 0.7857
- Supporting Reference Compounds
- 825
- E-value
- 6116.77
|
Click to view 3D structure | Nuclear receptor subfamily 1 group I member 2 | O75469 | Humans | Known | Not Available |
Click to view 3D structure | Sodium channel protein type 1 subunit alpha | P35498 | Humans | Known | This pyrethroid exerts its profound effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. This pyrethroid is a axonic poison that block the closing of the sodium gates in the nerves, and, thus, prolongs the return of the membrane potential to its resting state leading to hyperactivity of the nervous system which can result in paralysis and/or death. Type I Pyrethroid esters (lacking the alpha-cyano substituents) affect sodium channels in nerve membranes, causing repetitive (sensory, motor) neuronal discharge and a prolonged negative afterpotential, the effects being quite similar to those produced by DDT (L857, A560). |
Click to view 3D structure | Sodium channel protein type 10 subunit alpha | Q9Y5Y9 | Humans | Known | This pyrethroid exerts its profound effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. This pyrethroid is a axonic poison that block the closing of the sodium gates in the nerves, and, thus, prolongs the return of the membrane potential to its resting state leading to hyperactivity of the nervous system which can result in paralysis and/or death. Type I Pyrethroid esters (lacking the alpha-cyano substituents) affect sodium channels in nerve membranes, causing repetitive (sensory, motor) neuronal discharge and a prolonged negative afterpotential, the effects being quite similar to those produced by DDT (L857, A560). |
Click to view 3D structure | Sodium channel protein type 11 subunit alpha | Q9UI33 | Humans | Known | This pyrethroid exerts its profound effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. This pyrethroid is a axonic poison that block the closing of the sodium gates in the nerves, and, thus, prolongs the return of the membrane potential to its resting state leading to hyperactivity of the nervous system which can result in paralysis and/or death. Type I Pyrethroid esters (lacking the alpha-cyano substituents) affect sodium channels in nerve membranes, causing repetitive (sensory, motor) neuronal discharge and a prolonged negative afterpotential, the effects being quite similar to those produced by DDT (L857, A560). |
Click to view 3D structure | Sodium channel protein type 2 subunit alpha | Q99250 | Humans | Known | This pyrethroid exerts its profound effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. This pyrethroid is a axonic poison that block the closing of the sodium gates in the nerves, and, thus, prolongs the return of the membrane potential to its resting state leading to hyperactivity of the nervous system which can result in paralysis and/or death. Type I Pyrethroid esters (lacking the alpha-cyano substituents) affect sodium channels in nerve membranes, causing repetitive (sensory, motor) neuronal discharge and a prolonged negative afterpotential, the effects being quite similar to those produced by DDT (L857, A560). |
Click to view 3D structure | Sodium channel protein type 3 subunit alpha | Q9NY46 | Humans | Known | This pyrethroid exerts its profound effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. This pyrethroid is a axonic poison that block the closing of the sodium gates in the nerves, and, thus, prolongs the return of the membrane potential to its resting state leading to hyperactivity of the nervous system which can result in paralysis and/or death. Type I Pyrethroid esters (lacking the alpha-cyano substituents) affect sodium channels in nerve membranes, causing repetitive (sensory, motor) neuronal discharge and a prolonged negative afterpotential, the effects being quite similar to those produced by DDT (L857, A560). |
Click to view 3D structure | Sodium channel protein type 4 subunit alpha | P35499 | Humans | Known | This pyrethroid exerts its profound effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. This pyrethroid is a axonic poison that block the closing of the sodium gates in the nerves, and, thus, prolongs the return of the membrane potential to its resting state leading to hyperactivity of the nervous system which can result in paralysis and/or death. Type I Pyrethroid esters (lacking the alpha-cyano substituents) affect sodium channels in nerve membranes, causing repetitive (sensory, motor) neuronal discharge and a prolonged negative afterpotential, the effects being quite similar to those produced by DDT (L857, A560). |
Click to view 3D structure | Sodium channel protein type 5 subunit alpha | Q14524 | Humans | Known | This pyrethroid exerts its profound effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. This pyrethroid is a axonic poison that block the closing of the sodium gates in the nerves, and, thus, prolongs the return of the membrane potential to its resting state leading to hyperactivity of the nervous system which can result in paralysis and/or death. Type I Pyrethroid esters (lacking the alpha-cyano substituents) affect sodium channels in nerve membranes, causing repetitive (sensory, motor) neuronal discharge and a prolonged negative afterpotential, the effects being quite similar to those produced by DDT (L857, A560). |
Click to view 3D structure | Sodium channel protein type 8 subunit alpha | Q9UQD0 | Humans | Known | This pyrethroid exerts its profound effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. This pyrethroid is a axonic poison that block the closing of the sodium gates in the nerves, and, thus, prolongs the return of the membrane potential to its resting state leading to hyperactivity of the nervous system which can result in paralysis and/or death. Type I Pyrethroid esters (lacking the alpha-cyano substituents) affect sodium channels in nerve membranes, causing repetitive (sensory, motor) neuronal discharge and a prolonged negative afterpotential, the effects being quite similar to those produced by DDT (L857, A560). |
Click to view 3D structure | Sodium channel protein type 9 subunit alpha | Q15858 | Humans | Known | This pyrethroid exerts its profound effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. This pyrethroid is a axonic poison that block the closing of the sodium gates in the nerves, and, thus, prolongs the return of the membrane potential to its resting state leading to hyperactivity of the nervous system which can result in paralysis and/or death. Type I Pyrethroid esters (lacking the alpha-cyano substituents) affect sodium channels in nerve membranes, causing repetitive (sensory, motor) neuronal discharge and a prolonged negative afterpotential, the effects being quite similar to those produced by DDT (L857, A560). |
Click to view 3D structure | Sodium channel regulatory subunit beta-1 | Q07699 | Humans | Known | This pyrethroid exerts its profound effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. This pyrethroid is a axonic poison that block the closing of the sodium gates in the nerves, and, thus, prolongs the return of the membrane potential to its resting state leading to hyperactivity of the nervous system which can result in paralysis and/or death. Type I Pyrethroid esters (lacking the alpha-cyano substituents) affect sodium channels in nerve membranes, causing repetitive (sensory, motor) neuronal discharge and a prolonged negative afterpotential, the effects being quite similar to those produced by DDT (L857, A560). |
Click to view 3D structure | Sodium channel regulatory subunit beta-2 | O60939 | Humans | Known | This pyrethroid exerts its profound effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. This pyrethroid is a axonic poison that block the closing of the sodium gates in the nerves, and, thus, prolongs the return of the membrane potential to its resting state leading to hyperactivity of the nervous system which can result in paralysis and/or death. Type I Pyrethroid esters (lacking the alpha-cyano substituents) affect sodium channels in nerve membranes, causing repetitive (sensory, motor) neuronal discharge and a prolonged negative afterpotential, the effects being quite similar to those produced by DDT (L857, A560). |
Click to view 3D structure | Sodium channel regulatory subunit beta-3 | Q9NY72 | Humans | Known | This pyrethroid exerts its profound effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. This pyrethroid is a axonic poison that block the closing of the sodium gates in the nerves, and, thus, prolongs the return of the membrane potential to its resting state leading to hyperactivity of the nervous system which can result in paralysis and/or death. Type I Pyrethroid esters (lacking the alpha-cyano substituents) affect sodium channels in nerve membranes, causing repetitive (sensory, motor) neuronal discharge and a prolonged negative afterpotential, the effects being quite similar to those produced by DDT (L857, A560). |
Click to view 3D structure | Sodium channel regulatory subunit beta-4 | Q8IWT1 | Humans | Known | This pyrethroid exerts its profound effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. This pyrethroid is a axonic poison that block the closing of the sodium gates in the nerves, and, thus, prolongs the return of the membrane potential to its resting state leading to hyperactivity of the nervous system which can result in paralysis and/or death. Type I Pyrethroid esters (lacking the alpha-cyano substituents) affect sodium channels in nerve membranes, causing repetitive (sensory, motor) neuronal discharge and a prolonged negative afterpotential, the effects being quite similar to those produced by DDT (L857, A560). |
Click to view 3D structure | Calcium-transporting ATPase type 2C member 1 | P98194 | Humans | Known | This pyrethroid inhibits Na+/K+ ATPase and Ca2+ and Mg2+ ATPase, which are essential for the transport of calcium across membranes. This results in the accumulation of intracellular free calcium ions, which promotes release of neurotransmitters from storage vesicles, the subsequent depolarization of adjacent neurons, and the propagation of stimuli throughout the central nervous system. (T10) |
Click to view 3D structure | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | O14983 | Humans | Known | This pyrethroid inhibits Na+/K+ ATPase and Ca2+ and Mg2+ ATPase, which are essential for the transport of calcium across membranes. This results in the accumulation of intracellular free calcium ions, which promotes release of neurotransmitters from storage vesicles, the subsequent depolarization of adjacent neurons, and the propagation of stimuli throughout the central nervous system. (T10) |
Click to view 3D structure | Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | P16615 | Humans | Known | This pyrethroid inhibits Na+/K+ ATPase and Ca2+ and Mg2+ ATPase, which are essential for the transport of calcium across membranes. This results in the accumulation of intracellular free calcium ions, which promotes release of neurotransmitters from storage vesicles, the subsequent depolarization of adjacent neurons, and the propagation of stimuli throughout the central nervous system. (T10) |
Click to view 3D structure | Solute carrier organic anion transporter family member 1B1 | Q9Y6L6 | Humans | Known | Not Available |
Click to view 3D structure | C-C motif chemokine 2 | P13500 | Humans | Known | Not Available |
Click to view 3D structure | Collagen alpha-1(III) chain | P02461 | Humans | Known | Not Available |
Click to view 3D structure | Urokinase-type plasminogen activator | P00749 | Humans | Known | Not Available |
Click to view 3D structure | Sulfotransferase 2A1 | Q06520 | Humans | Known | Not Available |
Click to view 3D structure | Beta-secretase 1 | P56817 | Humans | Known | Not Available |
Click to view 3D structure | Cytochrome P450 2B6 | P20813 | Humans | Known | Not Available |
Click to view 3D structure | UDP-glucuronosyltransferase 1A1 | P22309 | Humans | Known | Not Available |
Click to view 3D structure | Cytochrome P450 1A2 | P05177 | Humans | Known | Not Available |
Click to view 3D structure | Peroxisome proliferator-activated receptor alpha | Q07869 | Humans | Known | Not Available |
Click to view 3D structure | Cytochrome P450 2C19 | P33261 | Humans | Known | Not Available |
Click to view 3D structure | 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial | O15528 | Humans | Known | Not Available |
Click to view 3D structure | Vitamin D3 receptor | P11473 | Humans | Known | Not Available |